Stay updated on Gilteritinib vs Midostaurin in AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib vs Midostaurin in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib vs Midostaurin in AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-04-30T13:56:33.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    0.9%
    Check dated 2025-04-16T02:11:12.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding a new date of December 17, 2024.
    Difference
    1%
    Check dated 2025-04-08T23:52:34.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-03-03T22:23:08.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    5%
    Check dated 2025-02-10T09:47:18.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T07:52:57.000Z thumbnail image

Stay in the know with updates to Gilteritinib vs Midostaurin in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib vs Midostaurin in AML Clinical Trial page.